What is Domadol (tramadol/paracetamol) and what are the recommended adult dosing guidelines and contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Domadol: Tramadol/Paracetamol Combination Analgesic

Domadol is a fixed-dose combination of tramadol 37.5 mg and paracetamol (acetaminophen) 325 mg per tablet, indicated for moderate to moderately severe pain in adults 17 years and older, with a maximum daily dose of 400 mg tramadol (approximately 8 tablets) and specific titration protocols to minimize adverse effects 1.

Medication Overview

Domadol combines two complementary analgesic mechanisms:

  • Tramadol: Atypical opioid with μ-receptor agonist activity plus serotonin-norepinephrine reuptake inhibition
  • Paracetamol: Non-opioid analgesic with central and peripheral effects

This combination provides synergistic analgesia with rapid onset (from paracetamol) and sustained duration (from tramadol) 2, 3.

Adult Dosing Guidelines

Standard Titration Protocol (Preferred for Chronic Pain)

Start low and titrate slowly to maximize tolerability 1:

  • Week 1: Start 25 mg tramadol (approximately 2/3 tablet) once daily in morning
  • Days 4-6: Increase to 25 mg four times daily (100 mg/day total)
  • Days 7-9: Increase by 50 mg increments every 3 days as tolerated
  • Target maintenance: 200 mg/day (50 mg four times daily = approximately 5-6 tablets)
  • Maximum: 400 mg tramadol/day (8 tablets), dosed every 4-6 hours as needed

Rapid-Onset Protocol (Acute Pain)

For patients requiring immediate analgesia where benefits outweigh discontinuation risks 1:

  • Dose: 1-2 tablets (37.5-75 mg tramadol) every 4-6 hours as needed
  • Maximum: 8 tablets/day (400 mg tramadol)

Note: This approach has higher discontinuation rates due to adverse effects but may be necessary for acute severe pain 2, 4.

Special Population Dosing

Renal Impairment

  • CrCl <30 mL/min: Increase dosing interval to every 12 hours, maximum 200 mg tramadol/day (approximately 5 tablets) 1
  • Hemodialysis: Give regular dose on dialysis days (only 7% removed by dialysis) 1

Hepatic Impairment

  • Cirrhosis: 50 mg tramadol every 12 hours (approximately 1.5 tablets twice daily) 1

Elderly Patients

  • Age 65-75: Start at lowest dose, titrate cautiously 1
  • Age >75: Maximum 300 mg tramadol/day (approximately 6 tablets) 1

Key Contraindications and Precautions

Absolute Contraindications

  • Hypersensitivity to tramadol, paracetamol, or opioids
  • Acute intoxication with alcohol, hypnotics, analgesics, or psychotropic drugs
  • Concurrent or recent (within 14 days) MAO inhibitor use
  • Severe hepatic impairment (paracetamol hepatotoxicity risk)

Critical Drug Interactions

  • Serotonergic agents (SSRIs, SNRIs, MAOIs): Risk of serotonin syndrome 5, 6
  • CNS depressants: Enhanced respiratory depression
  • CYP2D6 inhibitors/inducers: Alter tramadol metabolism and efficacy

Monitoring Requirements

  • Respiratory function: Tramadol causes dose-dependent respiratory depression, though less than pure opioids 6
  • Seizure risk: Tramadol lowers seizure threshold, particularly at higher doses or with predisposing factors 5
  • Cardiovascular status: Monitor for bradycardia and hypotension 4
  • Hepatic function: Paracetamol component requires monitoring for hepatotoxicity

Clinical Efficacy Context

The combination demonstrates superior analgesia compared to either component alone 2, 3, 7:

  • Acute pain: Effective for postoperative, dental, and musculoskeletal pain with efficacy comparable to hydrocodone/paracetamol 2, 7
  • Chronic pain: Useful for osteoarthritis, low back pain, and cancer-related pain when added to existing NSAID therapy 8, 4
  • Onset: Rapid (similar to paracetamol alone, approximately 30 minutes)
  • Duration: Sustained (6-8 hours) 3

Opioid Risk Considerations

Tramadol is classified as an opioid with morphine milligram equivalent (MME) conversion factor of 0.1 9. However, the CDC guideline notes uncertainty whether tramadol's overdose risk follows the same dose-dependent pattern as pure μ-receptor agonists due to its mixed mechanism 9.

At maximum Domadol dosing (400 mg tramadol/day), this equals 40 MME/day, which falls below the 50 MME/day threshold where opioid risks begin escalating significantly 9. This makes Domadol a relatively safer opioid option when used at recommended doses.

Common Pitfalls to Avoid

  • Incorrect dose measurement: Tramadol drops require careful measurement; dosing errors are common 10
  • Rapid titration: Increases nausea, vomiting, and discontinuation rates 1
  • Exceeding paracetamol limits: Monitor total daily paracetamol from all sources (maximum 4000 mg/day)
  • Abrupt discontinuation: Tramadol causes withdrawal symptoms; taper gradually if used >1 week 5
  • Underestimating addiction potential: Despite lower potency, tramadol carries dependence risk with chronic use 5

Adverse Effect Profile

Most common adverse effects mirror tramadol monotherapy 2, 7:

  • Nausea and vomiting (most frequent)
  • Dizziness and drowsiness
  • Constipation
  • Headache

Serious but rare: Seizures, serotonin syndrome, respiratory depression, anaphylaxis 5, 6

The combination does not increase adverse effects compared to tramadol alone, making it favorable over higher-dose tramadol monotherapy 2, 3.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.